Charles River Laboratories vs Syngene International

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/syngeneintl

Category	Charles River Laboratories	Syngene International
Listed site	both	both
Summary	Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.	Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Services	CMC Regulatory Submission Support Quality Control Testing Technology Transfer Formulation Development Process Development Cell Therapy Manufacturing Viral Vector Manufacturing Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Upstream Processing Downstream Processing CMC Analytical Development Stability Testing & Storage Cell-Line Development Microbial Fermentation Small Molecule Development & Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Sterile Fill-Finish & Aseptic Manufacturing	Discovery Research Medicinal Chemistry Computational & In-Silico Drug Discovery In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology GLP Toxicology Analytical Method Development & Validation Formulation Development Process Development CMC Analytical Development Small Molecule Development & Manufacturing API Synthesis & Manufacturing Sterile Fill-Finish & Aseptic Manufacturing Vial Filling Prefilled Syringe (PFS) Filling Cell-Line Development Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing Upstream Processing Downstream Processing Bioanalysis Peptide Manufacturing Oligonucleotide Manufacturing ADC (Antibody-Drug Conjugate) Manufacturing Cell Therapy Manufacturing mRNA Manufacturing Translational Research High-Throughput Screening Genetic Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Clinical Trial Services Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Data Management & eClinical Biostatistics & Statistical Programming Pharmacovigilance & Drug Safety Medical Writing Central Laboratory Services Clinical Imaging Core Lab Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy ICH Stability Studies Companion Diagnostics Development Microbiology Services Virology Services Immunology & Inflammation Services Oncology Specialty Services CNS Specialty Services Cardiovascular & Metabolic Specialty Services Pathology & Histology Services Genomics & Sequencing Services Proteomics Services Bioinformatics & Data Science Device & Combination Product Services HPAPI Manufacturing (High-Potency) Controlled Substance Manufacturing Flow Chemistry & Continuous Manufacturing Solid-State Chemistry & Polymorph Screening Microbial Fermentation ADC Payload & Linker Synthesis Bioconjugation Services Viral Vector Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Lipid Nanoparticle (LNP) Formulation Vaccine Manufacturing Microbiome / Live Biotherapeutic Manufacturing Cartridge Filling Lyophilization (Freeze Drying) Oral Solid Dosage Manufacturing Topical & Semi-Solid Manufacturing Inhalation & Nasal Dosage Manufacturing Ophthalmic Manufacturing Technology Transfer Quality Control Testing Stability Testing & Storage Extractables & Leachables Studies Secondary Packaging & Labeling Serialization & Track-and-Trace
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy AAV / Viral Vector Platform	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Peptide Oligonucleotide Antibody-Drug Conjugate (ADC) Cell Therapy mRNA Gene Therapy Vaccine
Indications	Oncology Immunology Neurology	Rare Disease Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	Headquarters, United States North America, North America, USA/Canada Europe, Europe, Multiple Asia, Asia, Multiple North America, North America Europe, Europe Asia, Asia	Headquarters, Bangalore, Karnataka, India U.S. Biologics Facility, United States U.S. Biologics Facility, San Diego, California, United States
Certifications	FDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: 100 IND submissions containing Retrogenix® platform data PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: Retrogenix® platform data support PMDA · Identifier: Retrogenix® platform data support	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.